World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
48
Citations
15075
World Ranking
4386
National Ranking
1990

Overview

Hillel S. Panitch was affiliated with the University of Vermont in the United States during their academic career. Their work focused primarily on research within the university setting until their passing.

Information regarding their research fields, publication history, and collaborative efforts is limited. No specific data on recent papers, including titles, publication years, or venues, has been documented. Likewise, there is no record of frequent coauthors or commonly featured publication venues associated with their work.

No topics, subfields, or main fields of study have been provided, leaving the precise academic focus areas unreported. Similarly, there are no entries cataloging book publications or awards received during their career.

Due to the absence of details on their specific contributions or recognitions, the profile remains highly concise and limited to their institutional affiliation and status as deceased.

Best Publications

  • Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial†

    Kathleen Hawker;Paul O'Connor;Mark S. Freedman;Peter A. Calabresi

  • Treatment of multiple sclerosis with gamma interferon

    Unknown

  • Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange

    Mark Keegan;Fatima König;Robyn McClelland;Wolfgang Brück

  • Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo- controlled, randomized phase II trial

    Ludwig Kappos;Giancarlo Comi;Hillel Panitch;Joel Oger

  • Systemic recombinant human interferon-β treatment of relapsing-remitting multiple sclerosis : pilot study analysis and six-year follow-up

    R.L. Knobler;J.I. Greenstein;K.P. Johnson;F.D. Lublin

  • Plasmapheresis in multiple sclerosis: Preliminary findings

    Peter C. Dau;Jack H. Petajan;Kenneth P. Johnson;Hillel S. Panitch

  • Lymphocytes from multiple sclerosis patients produce elevated levels of gamma interferonin vitro

    Unknown

  • Cytokine changes during interferon-beta therapy in multiple sclerosis: correlations with interferon dose and MRI response.

    Jerome J. Graber;David Ford;Min Zhan;Gordon Francis

  • Additive effects of copolymer-1 and interferon β-1b on the immune response to myelin basic protein

    Ron Milo;Hillel Panitch

  • Glatiramer acetate blocks the activation of THP-1 cells by interferon-γ

    Qingdi Li;Ron Milo;Ron Milo;Hillel Panitch;Hillel Panitch;Peggy Swoveland;Peggy Swoveland

  • Subacute sclerosing panencephalitis: remission after treatment withintraventricular interferon

    Unknown

  • Adoptive transfer of experimental allergic encephalomyelitis with activated spleen cells: comparison of in vitro activation by concanavalin a and myelin basic protein

    Hillel S. Panitch;Hillel S. Panitch

  • Interferon-β-1a induces increases in vascular cell adhesion molecule: Implications for its mode of action in multiple sclerosis

    J. Graber;M. Zhan;D. Ford;F. Kursch

  • Recurrent herpes simplex encephalitis: Recovery of virus after Ara-A treatment

    Dix Rd;Baringer;Panitch Hs;Rosenberg Sh

  • Immunological studies of scrapie infection

    Kenneth C. Kasper;Daniel P. Stites;Karen A. Bowman;Hillel Panitch

  • Gamma-interferon induction in patients with chronic progressive MS.

    C. T. Bever;H. S. Panitch;H. B. Levy;D. E. McFarlin

  • Serial immunological studies in multiple sclerosis patients treated systemically with human alpha interferon.

    Hillel S. Panitch;Hillel S. Panitch;Hillel S. Panitch;Gordon S. Francis;Gordon S. Francis;Carol J. Hooper;Carol J. Hooper;Thomas C. Merigan;Thomas C. Merigan

  • Adoptive transfer of experimental allergic encephalomyelitis: Requirement for macrophages in activation of spleen cells in vitro by concanavalin A or myelin basic protein

    Hillel S. Panitch;Hillel S. Panitch;Carlo Ciccone;Carlo Ciccone

  • Clinical trial of natural alpha interferon in multiple sclerosis.

    Robert L. Knobler;Hillel S. Panitch;Sherry L. Braheny;Jack C. Sipe

  • Use of aggregating brain cultures to study the replication of herpes simplex virus types 1 and 2 in central nervous system tissue

    L Pulliam;R D Dix;H S Panitch;J R Baringer

  • T8 antigen density on peripheral blood lymphocytes remains unchanged during exacerbations of multiple sclerosis

    Robert L. Hirsch;Jose Ordonez;Hillel S. Panitch;Hillel S. Panitch;Kenneth P. Johnson;Kenneth P. Johnson

  • Serial combination therapy: is immune modulation in multiple sclerosis enhanced by initial immune suppression?:

    Bar-Or A;Oger J;Gibbs E;Niino M

  • Decreased interferon synthesis and responsiveness to interferon by leukocytes from multiple sclerosis patients given natural alpha interferon.

    Roberta M. Kamin-Lewis;Hillel S. Panitch;Thomas C. Merigan;Kenneth P. Johnson

  • Antibodies to Myelin Basic Protein in Cerebrospinal Fluid of Patients with Multiple Sclerosis

    H. S. Panitch;D. A. Hafler;K. P. Johnson

  • Effect of antiviral agents on replication of herpes simplex virus type 1 in brain cultures.

    L Pulliam;H S Panitch;J R Baringer;R D Dix

  • Leukocytes from multiple sclerosis patients respond to α- and γ-interferons

    Roberta M. Kamin-Lewis;Roberta M. Kamin-Lewis;Hillel S. Panitch;Hillel S. Panitch;Kenneth P. Johnson;Kenneth P. Johnson

Frequent Co-Authors

Thomas C. Merigan
Thomas C. Merigan Stanford University
Michael J. Aminoff
Michael J. Aminoff University of California, San Francisco
David A. Hafler
David A. Hafler Yale University
Michael B. A. Oldstone
Michael B. A. Oldstone Scripps Research Institute
Howard L. Weiner
Howard L. Weiner Harvard University
David Norman
David Norman University of California, San Francisco
Robert A. Kyle
Robert A. Kyle Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to diverse healthcare careers, many of which benefit from advanced nursing qualifications. For those aiming to enhance their clinical expertise, exploring an accelerated nurse practitioner programs can be a strategic move, especially for individuals transitioning from a nursing background. These programs offer a fast track to specialized roles that integrate immunology with patient care.

Nurses interested in specialized acute care may consider obtaining an acute care certification for FNP. This certification equips Family Nurse Practitioners with the skills necessary to manage critically ill patients, blending immunology knowledge with acute clinical interventions.

For those new to nursing, enrolling in online ADN programs for non nurses offers an accessible pathway into the field. These degrees build foundational skills that support further specialization, including roles related to immunological health and disease management.

Career planning should also consider financial rewards. Understanding the dnp salary by specialty helps prospective students gauge the economic benefits of pursuing a Doctor of Nursing Practice in immunology-related fields. This insight supports informed decisions about education and career trajectories.

Best Scientists Citing Hillel S. Panitch

Recently Published Articles